All the data that support the findings of this study are available from Know Your Heart Study (<https://knowyourheart.science>) subject to scientific approval of a study protocol. Researchers wishing to get access to the study data can visit the metadata website: <https://metadata.knowyourheart.science>. The authors of this study had no special access privileges others would not have.

Introduction {#sec005}
============

Once detected, hypertension is relatively easy to treat, thereby reducing markedly the risk of complications. Yet many people live for a long time unaware that they have it. A first step in addressing this problem is to determine who, within a population, are most likely to have hypertension that is undetected and untreated. This has been addressed in many populations by studies of the closely associated reasons for non-attendance at general health checks and non-adherence to prescription drugs. These studies point to the importance of knowledge, time, resources, social support, certain beliefs, capability, opportunity, and motivation at the level of the individual and investment in education, healthcare technologies, and healthcare systems at a societal level. Policy responses often focus on the latter, for example through measures to encourage health workers to identify and treat hypertension and to ensure reliable supplies of medicines. Yet, even when well-functioning health systems exist, if those involved fail to recognise the burden on the individual who must change their health seeking and maintaining behaviours to avoid cardiovascular disease (CVD) then failure is likely \[[@pone.0233801.ref001],[@pone.0233801.ref002]\]. This makes it necessary to understand the complex barriers and facilitators to diagnosis and treatment and how they vary within populations, and especially those groups that are hard-to-reach.

Studies of non-attendance at general health checks found that those most likely to miss out include the less well educated, less affluent, younger, males, lacking social support, struggling to overcome barriers in terms of geographical and physical access, perceiving themselves not at risk, not yet having a CVD, or smokers \[[@pone.0233801.ref003],[@pone.0233801.ref004]\]. Studies of non-adherence to prescription drugs are similar, but also list forgetfulness \[[@pone.0233801.ref005]\] and factors related to therapy such as adverse drug reactions, prescription error, ineffective and counterfeit drugs, drugs not perceived effective, prescription costs, cumbersome refill prescription systems, beliefs in supplements and alternative remedies lacking scientifically proven efficacy or safety records \[[@pone.0233801.ref006]\].

In this paper we look at factors associated with untreated hypertension in Russian 35--69 year olds. Russia has very high CVD mortality compared to countries at similar levels of economic development and untreated hypertension is a persisting and important challenge to CVD prevention even though the Russian primary care system is free at the point of use. It has also established a programme of general health checks, offered to the entire adult population, called dispansarisation. This has been expanded progressively since 2013 \[[@pone.0233801.ref007]--[@pone.0233801.ref011]\].

The aims of the study were to determine the prevalence of untreated hypertension in population samples of two Russian cities, Arkhangelsk and Novosibirsk, and to identify factors associated with untreated hypertension in these two populations.

Materials and methods {#sec006}
=====================

Population sample {#sec007}
-----------------

In this study we used data from the Know Your Heart (KYH), a cross-sectional study of cardiovascular structure, function and risk factors in over 4,500 men and women aged 35--69 years from two Russian cities, Arkhangelsk and Novosibirsk, in 2015--2018 \[[@pone.0233801.ref012]\]. In brief, the study was conducted in three stages: 1) background interview; 2) health check; 3) repeat health check. A list of residential addresses was drawn at random from a population list stratified by age, sex, district, and city. Trained interviewers visited the addresses and conducted the baseline interview. At the interview, respondents were invited to take part in a health check in a local polyclinic, which included blood pressure measurements. Finally, a stratified random sample of respondents were invited back a year later for a repeat health check. Response rates for the health check component in KYH was 51% in Arkhangelsk and 22% in Novosibirsk based on denominators excluding addresses not found and addresses without at least one person of expected age and gender \[[@pone.0233801.ref012]\]. 2,353 participants were selected for this study, based on the following inclusion criteria: aged 35--69 years, recorded systolic and diastolic blood pressure, hypertension (blood pressure at or above 140/90 mmHg) or taking antihypertensive medication.

Screening examination {#sec008}
---------------------

Blood pressure was measured in KYH using OMRON 705 IT automatic blood pressure monitors (OMRON Healthcare). All devices were calibrated before and after the fieldwork period and no adjustments were needed.

Participants were assigned to different antihypertensive classes based on their systolic and diastolic blood pressure (average of last two out of three measurements) according to the European hypertension treatment guidelines \[[@pone.0233801.ref013]\] and antihypertensive use. The thresholds for hypertension were a systolic pressure of 140 mmHg or more and/or a diastolic of 90 mmHg or more (office measurement) \[[@pone.0233801.ref013]\]. Antihypertensive medications were self-reported and comprised those falling within the WHO Anatomical Therapeutic Chemical (ATC) \[[@pone.0233801.ref014]\] classification system ATC classes, C02, C03, C07, C08, or C09. The main analyses were based on ATC code alone. Sensitivity analyses were conducted using self-reported use of antihypertensive (irrespective of whether a relevant medication was identified among the ATC codes).

To address measurement error (biological variability and measurement method) a random sample of participants stratified by age and sex were invited back a year later for a repeated measurement. The distribution of those who attended the repeated measurement (N = 332) versus those who did not (N = 3,770) is shown in [S3 Table](#pone.0233801.s003){ref-type="supplementary-material"}. The sample for this part of the study was larger and included all participants and not only those found to have hypertension. To estimate measurement error, only data from participants not on antihypertensive medications and with blood pressures in the normal range (systolic \<140 mmHg; diastolic \<90 mmHg) at both visits were selected to exclude those that were informed by the study that their blood pressure was too high at the first visit as well as those on treatment. Standard deviation within subjects and within-subject coefficients of variance were calculated \[[@pone.0233801.ref015]\]. The prevalence of different hypertension status outcomes at the second measurement were calculated and standardised to 2013 European Standard Population for those who were initially found with untreated hypertension.

Definition of risk factors {#sec009}
--------------------------

Level of education was categorised into four groups: elementary (incomplete secondary, professional no secondary), lower intermediate (complete secondary, professional and secondary), higher intermediate (specialised secondary, incomplete higher), graduate. Self-perceived financial constraints were categorized as: household perceived to be constrained in buying food or clothes versus constrained in buying large domestic appliances versus unconstrained in buying any of the above. Single status was defined as anyone not living with a partner. Self-reported alcohol consumption and alcohol-related behaviours were used to create three categories: Non-drinker past year versus low risk drinkers (score \<8) versus high risk drinkers (score 8+) according to WHO alcohol use disorder screening tool \[[@pone.0233801.ref016]\]. Physical activity was measured employing the Total physical activity index using the standard classification of inactive versus moderately inactive, moderately active, and active \[[@pone.0233801.ref017]\]. Diabetes status was ascertained on either self-reported diabetes, self-reported diabetes medication use (ATC A10: insulin or oral antidiabetics) or HbA1c 48+ mmol/mol (\>6.5%) \[[@pone.0233801.ref018]\]. Chronic kidney disease (CKD) status was defined as Glomerular Filtration Rate (eGFR) below 60ml/min/1.73m^2^ based on serum creatinine \[[@pone.0233801.ref019]\]. A variable for CVD history comprised any self-reported history of myocardial infarction, heart failure, atrial fibrillation, angina, or stroke events. The presence of depression was included in the analyses because it has been associated with CVD mortality, and specifically in Eastern European countries \[[@pone.0233801.ref020]\]. Here it was defined as having a score at and above 5 on the PHQ-9 instrument \[[@pone.0233801.ref021]\]. Attendance at a general health check was ascertained using a question about having attended the dispansarisation programme since its relaunch in 2013; this was used in the descriptive analysis \[[@pone.0233801.ref007]\]. Economic activity was defined according to responses to routed questions on retirement (baseline questionnaire item A11), regular paid work (A12), and other activity (A14). Hypertension knowledge was tested with a question about whether hypertension is believed to always, sometimes, or never be associated with symptoms.

Statistical analysis {#sec010}
--------------------

The prevalence of untreated hypertension was estimated and standardized by age and sex to the European Standard Population \[[@pone.0233801.ref022]\]. Gender-specific multivariate logistic regression models of untreated versus treated hypertension in 35--69 year olds adjusting for age or age and CVD history were fitted using Stata 15 \[[@pone.0233801.ref023]\]. A range of co-variates was included as potential factors associated with untreated hypertension, i.e. education, marital status, body mass index, alcohol consumption, depression (PHQ-9), and whether a primary care doctor was visited in the past year.

Ethical approval {#sec011}
----------------

The study complied with the 1964 Helsinki declaration and its later amendments and ethical approval was received from the ethics committees of London School of Hygiene and Tropical Medicine (approval number 8808), Novosibirsk State Medical University (approval number 75; 21 May 2015), the Institute of Preventative Medicine (approval received 26 December 2014), Novosibirsk and the Northern State Medical University, Arkhangelsk (approval number 01/01-15; 27 January 2015). Informed written consent was obtained from all individual participants included in the study.

Results {#sec012}
=======

The characteristics of the study participants (N = 2,353) are shown in [S1](#pone.0233801.s001){ref-type="supplementary-material"} and [S2](#pone.0233801.s002){ref-type="supplementary-material"} Tables. The prevalence by gender of the different hypertensive categories, including normotensives, can be found at [Fig 1](#pone.0233801.g001){ref-type="fig"}.

![Age-standardised prevalence (%) of hypertensive categories among 35--69 year olds by gender.](pone.0233801.g001){#pone.0233801.g001}

To address measurement error, a random sample of 332 participants (178 females and 154 males) were invited back a year later for a repeated measurement ([Fig 2](#pone.0233801.g002){ref-type="fig"}). 109 participants, normotensive at both visits, were selected. The mean duration between the two measurements was 359 days (SD 22). Standard deviation within subjects were 5.8 mmHg and 3.5 mmHg for systolic and diastolic measurements, respectively. The within-subject coefficients of variance for the same measurements were 5.0% and 4.6%.

![Hypertension status flows between first and repeated measurement for a subset of female (left panel; N = 178) and male (right; N = 154) 35--69 year olds.](pone.0233801.g002){#pone.0233801.g002}

For those in the repeated measurement sub-sample (N = 332) found to have untreated hypertension at the first visit, the most common trajectory for men was to be classified as having untreated hypertension again (55%; 95% CI 42--68) and only 17% (9--30) were on antihypertensive medications a year later. For women, the same proportions were 37% (22--54) and 37% (22--54).

The prevalence of untreated hypertension among those with hypertension was 51.1% (95% CI 47.8--54.5) for males, 28.8% (25.4--32.5) for females, and 40.0% (37.5--42.5) overall ([S3 Table](#pone.0233801.s003){ref-type="supplementary-material"}).

The factors associated with untreated hypertension relative to treated hypertension were younger ages, self-rated general health as very good-excellent, not being obese, no history of CVD events, no evidence of diabetes or CKD, and not seeing a primary care doctor in the past year as well as problem drinking for women and working full time, lower education, and smoking for men (Tables [1](#pone.0233801.t001){ref-type="table"} and [2](#pone.0233801.t002){ref-type="table"}). These effects held even when, in addition, adjusting for CVD history.

10.1371/journal.pone.0233801.t001

###### Logistic regression models of untreated versus treated hypertension among female participants (N = 1,265).

![](pone.0233801.t001){#pone.0233801.t001g}

  Characteristic                       Level                   AOR age    P-value   95% CI       AOR age/CVD   P-value   95% CI
  ------------------------------------ ----------------------- ---------- --------- ------------ ------------- --------- ------------
  CVD history                          No                      Ref                                                       
                                       Yes                     **0.26**   \< .001   0.18--0.38                           
  Age group                            35--49 yr               Ref                               Ref                     
                                       50--59 yr               **0.58**   .003      0.41--0.83   **0.67**      .031      0.46--0.96
                                       60--69 yr               **0.33**   \< .001   0.23--0.47   **0.46**      \< .001   0.32--0.66
  Education                            Elementary              Ref                               Ref                     
                                       Lower intermediate      1.35       .397      0.67--2.72   1.47          .290      0.72--2.99
                                       Higher intermediate     1.38       .329      0.72--2.65   1.48          .244      0.76--2.87
                                       Graduate                1.63       .148      0.84--3.17   1.63          .157      0.83--3.20
  Economic activity                    Retired                 Ref                               Ref                     
                                       Paid work               1.57       .073      0.96--2.57   1.45          .137      0.89--2.38
                                       Looking after home      0.91       .701      0.58--1.44   0.95          .818      0.59--1.51
                                       Unemployed              0.78       .711      0.20--2.97   0.82          .780      0.21--3.23
                                       Other                   2.16       .326      0.46--10.1   2.43          .276      0.49--12.0
  Household income                     Constrained             Ref                               Ref                     
                                       Intermediary            0.90       .543      0.64--1.26   0.83          .304      0.59--1.18
                                       Rel. unconstrained      1.12       .555      0.76--1.66   1.00          .976      0.68--1.50
  Single                               No                      Ref                               Ref                     
                                       Yes                     0.85       .265      0.65--1.13   0.92          .566      0.69--1.22
  Smoking                              No                      Ref                               Ref                     
                                       Yes                     1.21       .312      0.84--1.74   1.23          .270      0.85--1.79
  Alcohol use disorder                 Non-drinker past year   Ref                               Ref                     
                                       Low (AUDIT\<8)          1.15       .494      0.77--1.72   1.09          .684      0.72--1.64
                                       High (AUDIT 8+)         **3.55**   .002      1.61--7.84   **3.04**      .007      1.36--6.77
  Physical activity                    Inactive                Ref                               Ref                     
                                       Moderately inactive     1.34       .446      0.63--2.83   1.49          .306      0.70--3.18
                                       Moderately active       1.25       .500      0.65--2.40   1.39          .328      0.72--2.67
                                       Active                  1.08       .816      0.54--2.16   1.15          .697      0.57--2.30
  Self-rated general health            Poor/fair/good          Ref                               Ref                     
                                       Very good/excellent     **2.20**   \< .001   1.65--2.94   **1.97**      \< .001   1.47--2.64
  Body Mass Index                      Under/Normal (\<25)     Ref                               Ref                     
                                       Overweight (25--29)     1.00       .988      0.67--1.47   0.95          .800      0.64--1.41
                                       Obese (30--34)          **0.60**   .015      0.40--0.91   **0.60**      .019      0.40--0.92
                                       Very obese (35+)        **0.35**   \< .001   0.21--0.58   **0.35**      \< .001   0.21--0.58
  Diabetic                             No                      Ref                               Ref                     
                                       Yes                     **0.36**   \< .001   0.22--0.59   **0.38**      \< .001   0.23--0.63
  CKD                                  No                      Ref                               Ref                     
                                       Yes                     0.65       .187      0.35--1.23   0.70          .284      0.37--1.34
  Depression (PHQ-9)                   No                      Ref                               Ref                     
                                       Yes                     **0.67**   .006      0.51--0.89   0.76          .060      0.57--1.01
  Seen primary care doctor past year   No                      Ref                               Ref                     
                                       Yes                     **0.29**   \< .001   0.21--0.39   **0.32**      \< .001   0.23--0.43

Age- and CVD history-adjusted odds ratios (AOR) with 95% confidence intervals.

10.1371/journal.pone.0233801.t002

###### Logistic regression models of untreated versus treated hypertension among male participants (N = 1,088).

![](pone.0233801.t002){#pone.0233801.t002g}

  Characteristic                       Level                   AOR age    P-value   95% CI       AOR age/CVD   P-value   95% CI
  ------------------------------------ ----------------------- ---------- --------- ------------ ------------- --------- ------------
  CVD history                          No                      Ref                                                       
                                       Yes                     **0.23**   \< .001   0.17--0.32                           
  Age group                            35--49 yr               Ref                               Ref                     
                                       50--59 yr               **0.48**   \< .001   0.35--0.67   **0.57**      .002      0.40--0.81
                                       60--69 yr               **0.29**   \< .001   0.21--0.40   **0.41**      \< .001   0.30--0.58
  Education                            Elementary              Ref                               Ref                     
                                       Lower intermediate      0.68       .104      0.42--1.08   0.62          .062      0.38--1.02
                                       Higher intermediate     0.65       .061      0.42--1.02   **0.59**      .032      0.37--0.96
                                       Graduate                **0.59**   .022      0.38--0.93   **0.50**      .004      0.31--0.81
  Economic activity                    Retired                 Ref                               Ref                     
                                       Paid work               **1.92**   .001      1.31--2.81   **1.64**      .014      1.10--2.45
                                       Looking after home      1.05       .895      0.52--2.12   1.16          .694      0.55--2.45
                                       Unemployed              1.99       .083      0.91--4.33   2.22          .057      0.98--5.04
                                       Other                   1.33       .486      0.60--2.95   1.25          .604      0.54--2.85
  Household income                     Constrained             Ref                                                       
                                       Intermediary            1.04       .819      0.74--1.46   0.88          .497      0.62--1.26
                                       Rel. unconstrained      1.13       .522      0.78--1.62   0.84          .376      0.57--1.23
  Single                               No                      Ref                               Ref                     
                                       Yes                     1.40       .056      0.99--1.98   1.40          .068      0.98--2.00
  Smoking                              No                      Ref                               Ref                     
                                       Yes                     **1.39**   .012      1.07--1.80   **1.43**      .010      1.09--1.87
  Alcohol use disorder                 Non-drinker past year   Ref                               Ref                     
                                       Low (AUDIT\<8)          1.21       .198      0.90--1.63   1.13          .435      0.83--1.54
                                       High (AUDIT 8+)         1.33       .073      0.97--1.82   1.17          .342      0.85--1.63
  Physical activity                    Inactive                Ref                               Ref                     
                                       Moderately inactive     0.60       .148      0.30--1.20   0.64          .223      0.31--1.31
                                       Moderately active       0.67       .199      0.36--1.23   0.70          .266      0.37--1.32
                                       Active                  1.05       .886      0.56--1.96   1.02          .944      0.53--1.96
  Self-rated general health            Poor/fair/good          Ref                               Ref                     
                                       Very good/excellent     **2.18**   \< .001   1.69--2.81   **1.77**      \< .001   1.35--2.30
  Body Mass Index                      Under/Normal (\<25)     Ref                               Ref                     
                                       Overweight (25--29)     **0.58**   .001      0.42--0.80   **0.58**      .002      0.41--0.81
                                       Obese (30--34)          **0.32**   \< .001   0.22--0.47   **0.31**      \< .001   0.21--0.47
                                       Very obese (35+)        **0.20**   \< .001   0.11--0.35   **0.22**      \< .001   0.12--0.40
  Diabetic                             No                      Ref                               Ref                     
                                       Yes                     **0.26**   \< .001   0.16--0.41   **0.30**      \< .001   0.19--0.49
  CKD                                  No                      Ref                               Ref                     
                                       Yes                     **0.35**   .007      0.17--0.75   **0.44**      .040      0.20--0.96
  Depression (PHQ-9)                   No                      Ref                               Ref                     
                                       Yes                     **0.69**   .011      0.52--0.92   0.86          .337      0.64--1.17
  Seen primary care doctor past year   No                      Ref                               Ref                     
                                       Yes                     **0.35**   \< .001   0.27--0.46   **0.39**      \< .001   0.30--0.51

Age- and CVD history-adjusted odds ratios (AOR) with 95% confidence intervals.

For women, hypertension awareness was 85% among those with treated hypertension and 40% among those untreated ([S1 Table](#pone.0233801.s001){ref-type="supplementary-material"}). For men, the same proportions were similar, 85% and 38%, respectively ([S2 Table](#pone.0233801.s002){ref-type="supplementary-material"}).

For women, general health check attendance was 57% in those with untreated hypertension and 50% in those with treated hypertension ([S1 Table](#pone.0233801.s001){ref-type="supplementary-material"}). For men, 33% and 29% ([S2 Table](#pone.0233801.s002){ref-type="supplementary-material"}).

The majority of respondents was unaware that hypertension was an asymptomatic condition ([S1](#pone.0233801.s001){ref-type="supplementary-material"} and [S2](#pone.0233801.s002){ref-type="supplementary-material"} Tables). The most 'knowledgeable' were untreated men (17% of men knew the correct answer) and the least were treated women (8%).

Discussion {#sec013}
==========

Prevalence of untreated hypertension among the 35--69 year olds in this study was 51% in males, 29% in females, and 40% overall. Similar levels were found in the concurrent ESSE-RF Study carried out in a population-based sample of 25--64 year olds in four other Russian regions, i.e. 58% in men, 29% in women, and 47% overall \[[@pone.0233801.ref024]\]. In comparison, a study with data from 123 nationally representative surveys of 40--79 year olds in 12 high income countries \[[@pone.0233801.ref025]\] found that prevalence of untreated hypertension in males ranged from 19% in Canada to 61% in Ireland. For females, from 20% in Germany and the US to 50% in Ireland. The KYH study population would therefore fall into the mid-range for males and towards the best performing end for females. The prevalence in males was on par with Italy (44%), Australia (45%), Finland (45%), New Zealand (45%), UK (45%), Japan (48%), and Spain (49%). For women, it was on par with South Korea (26%), Germany (20%), and the US (20%). Common to the best performing countries, were that national clinical guidelines recommend treatment of blood pressures at and above 140/90 mmHg and a working general health check programme. Russian health professionals should follow European treatment guidelines, initiating treatment at blood pressures at and above 140/90 mmHg. The dispansarisation programme, expanded in 2013, is central to preventive efforts. At the time of data collection, in 2015--2018, among those with untreated hypertension 50% of women and 30% of men had attended a general health check since 2013 versus 57%/33% among those with treated hypertension. This indicates that the dispansarisation programme still has some way to go in terms of coverage. It should be noted that legislation enacted in 2019 aims to strengthen the dispansarisation programme further by offering it yearly to those aged 40 years and above, introducing an online appointment system for users and opening evening and Saturday appointments \[[@pone.0233801.ref011]\].

Untreated hypertension was found to be associated with younger ages, self-rated general health as very good-excellent, not being obese, no history of CVD events, no evidence of diabetes or CKD, and not seeing a primary care doctor in the past year as well as problem drinking for women and working full time, lower education, and smoking for men.

These findings are largely consistent with the literature on non-attendance to participatory health interventions and drug non-adherence \[[@pone.0233801.ref003],[@pone.0233801.ref004],[@pone.0233801.ref006],[@pone.0233801.ref026]\], although financial constraints were not found statistically significant or important. The ESSE-RF Study in Russia found younger ages and absence of CVD associated with untreated hypertension \[[@pone.0233801.ref024]\]. Other factors were rural residence and higher lipids in men and higher heart rates in women.

Interestingly, working full time for men was associated with untreated hypertension even after adjusting for age and CVD history. This suggests that not having sufficient time to navigate the healthcare system to get a health check and appropriate treatment could be a barrier, especially, for men. This finding points to a need to undertake more studies on how to lower the barriers for full time workers. To this end, under legislation enacted in 2018, workers are now entitled to paid leave when attending the dispansarisation health checks \[[@pone.0233801.ref027]\].

Of those with untreated hypertension, as many as 40% of women and 38% of men reported to have been diagnosed with hypertension at some point (hypertension awareness). Only 14% of women with untreated hypertension and 17% of men knew that hypertension was an asymptomatic condition. A study of first time attenders to a cardiology clinic in Moscow with six month follow-up similarly found absence of symptoms (73%) to be the most common reason given for non-adherence \[[@pone.0233801.ref005]\]. Less commonly given reasons were forgetfulness (31%), out-of-pockets costs (22%), non-eligibility of re-imbursement schemes (14%), side-effects (10%), treatment courses (7%), and polypharmacy (5%). This points to particular issues around health knowledge and medication adherence that should be studied further. Other studies have found the misconception that hypertension is a condition brought on temporarily by stress and that antihypertensive medications no longer need be taken if the feelings of stress pass \[[@pone.0233801.ref028]\].

For those with untreated hypertension at the first visit, the most common trajectory for men was to be diagnosed with untreated hypertension again (55%; 95% CI 42--68), 17% were on antihypertensive medications (9--30), and only 3.7% (0.9--14) with controlled hypertension a year later. For women, the same proportions were 37% (22--54), 37% (22--55), and 34% (19--53) ([Fig 1](#pone.0233801.g001){ref-type="fig"}). Although these findings were based on a very small number of participants, they do suggest that women are more likely than men to act upon health advice when informed about a preventable health issue such as untreated hypertension. This finding could inform encounters in general practice when prompting patients to take part in health checks as well as in public health campaigns tailored to male audiences.

Detection, treatment, and control of hypertension have improved internationally since the 1980s in high-income countries, yet control has stagnated since the mid- to late 2000s, pointing to a need for innovative strategies or interventions should be considered in addition to the existing measures. New interventions may exploit new technologies \[[@pone.0233801.ref025]\], raise awareness through large pragmatic studies such as the May Measurement Month project \[[@pone.0233801.ref029]\] where participants can contribute to international research, or explore new effective settings for outreach such as the example of the Los Angeles black barbershop trial \[[@pone.0233801.ref030]\]. At a more strategic level, there are examples of interventions that have achieved good results by offering comprehensive and contextualised care involving networks of non-physician health workers \[[@pone.0233801.ref031]\]. A recent review of the effectiveness of blood pressure control strategies with 100 articles concluded that multilevel, multicomponent strategies followed by patient-level strategies were the most efficient \[[@pone.0233801.ref032]\]. Examples of effective strategies included team-based care strategies and strategies providing training for home monitory of blood pressure and health coaching in primary care and community settings. The review also concluded that trial evidence on strategies involving electronic decision support systems is still sparse and should be evaluated further.

Limitations {#sec014}
-----------

Sampling bias introduced by non-response was assessed by comparing the realised sample against data from the Russian Census 2010 on age, gender, and higher education attainment \[[@pone.0233801.ref012]\]. Overall, the realised sample for the health check was close to equity, with a ratio of 0.99 (95% CI 0.93--1.06) for Arkhangelsk and 1.26 (1.17--1.34) for Novosibirsk. It cannot be excluded that non-responders could have been less likely to seek healthcare and adhere to medical advice than responders. Among those that did not attend the health check, there were relatively fewer with CVD and hypertension awareness at the baseline compared to those that did attend \[[@pone.0233801.ref012]\]. The true prevalence of untreated hypertension is therefore likely to be even higher than estimated in this study.

In addition to non-response biases, the study will by design have excluded institutionalised individuals, individuals with no fixed abode, and individuals too ill to be interviewed or to take part in the health check carried out at a local clinic, and as such may not be fully representative of groups that currently are hard to reach with public health interventions. This is a limitation that should be borne in mind when interpreting the results of the study.

The definition of hypertension used in this study relied on a precise measurement of blood pressure at a single time point. If there were a large measurement error associated with blood pressure measurement either due to biological variability or measurement method, this could affect the outcome variable and potentially dilute the purported associations with risk factors \[[@pone.0233801.ref033]\]. The within-individual standard variation was found to be relatively modest among individuals measured again a year later. Only individuals normotensive at both visits were included in this part of the study to, as far as possible, exclude factors associated with treatment as well as those who prompted by the results of the first visit could have sought further care or ameliorated their health behaviours accordingly.

Identification of those treated for hypertension was based on self-reported medication data but not every participant may have been aware of the indication for each medicine reported. As a sensitivity analysis, prevalence of untreated hypertension was calculated using a question on whether antihypertensive medications were taken, with similar results.

Conclusion {#sec015}
==========

The study found a relatively high prevalence of untreated hypertension, especially, in men. Initiatives to strengthen the primary care provision and the dispansarisation general health check programme making it yearly for those aged 40 years and above, extending hours, introducing Saturday appointments as well as paid leave for those in full time work to attend are promising. Further studies should however investigate whether more effective strategies could be designed to accommodate population needs in terms of detection and adherence to antihypertensive medications.

Supporting information {#sec016}
======================

###### Characteristics of female study participants: Treated versus untreated hypertension (N = 1,265).
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Click here for additional data file.

###### Characteristics of male study participants: Treated versus untreated hypertension (N = 1,088).
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Click here for additional data file.

###### Prevalence (%) of untreated hypertension among hypertensive 35--69 year olds.
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###### Characteristics of study participants with any hypertension status incl. normotensive (N = 4,102): Without repeated measurement versus with repeated measurement.
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Dear Dr. PETERSEN,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I agree with both reviewers your manuscript can benefit from subheadings and better structuring of the Methods section.

Also provide more details on study population selection and expand the discussion section on how to make inferences about generalizability of odds ratios given the difference in participation rates between the two urban populations. Are these still valid or would the estimation of odds ratios be affected due to the selection process? 

Reviewer 2 makes an important point about including psychosocial CVD risk factors such as depression, anxiety and stress. These variables should be included in the multivariable analysis when available.

Please also provide results from a logistic regression model including all variables (not only adjusted for age and CVD, but adjusting with all other variables) and test for interaction by gender (within one comprehensive model, not separated by gender). 

We would appreciate receiving your revised manuscript by Apr 02 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>
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A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.
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Bart Ferket

Academic Editor
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3\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.
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b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.
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**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: I Don\'t Know

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The aim of the study is not clearly stated. I just assume it was (1) to determine the prevalence of untreated hypertension in population samples of Arkhangelsk and Novosibirsk and (2) to identify factors to be associated with untreated hypertension in the two population samples.

Section Materials and methods should be clearly structured having the following subsections:

Population -- this should also include how the individuals were selected

Screening examination -- should be briefly described, including blood pressure measurement

Definition of risk factors, incl. hypertension. The definition of hypertension used on lines 117 and 118 does not seem to include values equal to 140/90 mmHg, which is not in agreement with the quoted European guidelines on hypertension.

Statistical analysis

In conclusion, it is an important study which has to be published, however, the current version needs a major revision.

Reviewer \#2: The submitted manuscript assesses the rate of untreated hypertension based on the «Know Your Heart» study and is carried out in two Russian cities, namely Novosibirsk and Arkhangelsk. The aim was also to provide further insights into the country-specific factors contributing to the fact that far too many hypertensive men and women currently remain untreated. However, there are a number of points, which need clarifications and revision.

1\) The Materials and Methods section is not enough conclusive. It is difficult to understand the methodology of the study. Although authors provided a reference to their comprehensive paper on the «Know Your Heart» study design \[Cook S, Malyutina S, Kudryavtsev AV, et al. Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18. Wellcome Open Res. 2018;3:67.\], it is not enough. I recommend to give in the current paper at least basic explanations on how the study population was selected.

2\) The description of statistical methods is very scarce; they are presented literally in a couple of sentences and are not allocated in a separate subsection.

3\) The robustness of results seems doubtful due to a low response rate. Moreover, the response rate in Novosibirsk, which is a developed city with a population of more than 1.5 million people, was more than two times lower than in Arkhangelsk (22% vs 51%, respectively). This issue must be addressed in some way.

4\) Within the scope of the studied problems, the psychosocial CVD risk factors such as depression, anxiety and stress are shown to be of great importance for the Russian population. These factors serve as barriers for traditional risk factors modification and CVD treatment, including hypertension treatment, and they are also known to independently affect long-term health outcomes in CVD patients. According to the design paper, the "Know Your Heart" study encompassed assessment of anxiety and depression (using validated questionnaires), as well as assessment of self-reported social support. It is not clear, why these data were not used in the multivariate logistic regression models of untreated vs treated hypertension in this paper. The inclusion of these data into the models may provide more accurate and comprehensive information on factors, associated with lack of antihypertensive treatment, specifically relevant for the Russian population.

5\) I would recommend avoiding inappropriate slang expressions like antihypertensives instead of antihypertensive drugs or medicines or treatment.

Given all of the above, this article needs a major revision before publication.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Renata Cifkova

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Dear Dr Bart Ferket,

Please find our response to the reviewers' comments below. We found the comments constructive and feel that the process has strengthened the paper.

Many regards and on behalf of the author team,

Jakob Petersen

London, 03 March 2020

Attachments: Response to Reviewers, Revised Manuscript with Track Changes, Manuscript

Editor's comments

I agree with both reviewers your manuscript can benefit from subheadings and better structuring of the Methods section.

Response:

We agree that the structure and content suggested by the reviewers will make the Methods section much clearer. We have now restructured and expanded it accordingly.

Also provide more details on study population selection and expand the discussion section on how to make inferences about generalizability of odds ratios given the difference in participation rates between the two urban populations. Are these still valid or would the estimation of odds ratios be affected due to the selection process?

Response:

We agree that the low response rate, especially in one of the two cities, could lead to sampling bias. We currently discuss this in the Limitations sub-section, where we refer to analyses carried out by Cook et al. (2018) in our earlier paper on the study methodology. Cook et al. compared age, sex, and higher education attainment of respondents with the Russian 2010 Census population of each city. The results showed that the sample attending for the health check was almost the same as that in the Census, with a ratio of 0.99 (95% CI 0.93-1.06) for Arkhangelsk and 1.26 (1.17-1.34) for Novosibirsk.

We also note that our prevalence estimates of untreated hypertension were very close to the concurrent ESSE-RF Study of 25-64 year olds in four other Russian regions (Balanova et al. 2019).

We feel that the relatively low response rate needs to be acknowledged when interpreting the results. Based on the comparison with the Russian Census population we have no good reason to conclude that the respondents differed markedly in terms of age, sex, and higher education attainment.

Reviewer 2 makes an important point about including psychosocial CVD risk factors such as depression, anxiety and stress. These variables should be included in the multivariable analysis when available.

Response:

We agree and now include a reference in support of this suggestion and have included depression status (PHQ-9 instrument) in the analyses. Given that the constructs for depression, anxiety, and stress are related, we suggest that only the most severe of the three, i.e. depression, is included.

Please also provide results from a logistic regression model including all variables (not only adjusted for age and CVD, but adjusting with all other variables) and test for interaction by gender (within one comprehensive model, not separated by gender).

Response:

We present the joint model for both genders below (age- and sex-adjusted and fully adjusted odds ratios). No significant interactions between age group and gender were found. This was tested with a likelihood ratio test in the full model without an interaction term versus the full model with an interaction term.

It is well known that men and women differ in health behaviours, for many reasons including gender norms and expectations and targeted marketing of unhealthy products, and we suggest to keep the gender-specific regression tables.

Table Logistic regression models of untreated versus treated hypertension. Age- and fully adjusted odds ratios (AOR) with 95% confidence intervals.

Characteristic Level AOR age/sex P-value 95% CI AOR all P-value 95% CI

Gender Female Ref Ref

Male 2.74 \<.001 2.28-3.29 1.67 \<.001 1.28-2.19

CVD history No Ref Ref

Yes 0.24 \<.001 0.19-0.31 0.31 \<.001 0.24-0.40

Age group 35-49 yr Ref Ref

50-59 yr 0.53 \<.001 0.41-0.67 0.71 .034 0.51-0.97

60-69 yr 0.31 \<.001 0.24-0.39 0.63 .017 0.43-0.92

Education Elementary Ref Ref

Lower intermediate 0.84 .368 0.58-1.23 0.85 .450 0.56-1.30

Higher intermediate 0.83 .290 0.58-1.18 0.80 .265 0.54-1.19

Graduate 0.84 .336 0.59-1.20 0.71 .106 0.47-1.07

Economic activity Retired Ref Ref

Paid work 1.71 \<.001 1.28-2.29 1.39 .051 1.00-1.94

Looking after home 0.96 .833 0.66-1.40 0.89 .599 0.58-1.37

Unemployed 1.41 .286 0.75-2.67 1.76 .132 0.84-3.67

Other 1.38 .369 0.68-2.81 0.92 .848 0.41-2.09

Household income Constrained Ref Ref

Intermediary 0.97 .801 0.76-1.23 0.83 .181 0.63-1.09

Rel. unconstrained 1.11 .437 0.85-1.45 0.87 .393 0.63-1.20

Single No Ref Ref

Yes 1.04 .734 0.84-1.29 1.02 .876 0.80-1.30

Smoking No Ref Ref

Yes 1.32 .009 1.07-1.63 1.14 .305 0.89-1.46

Alcohol use disorder Non-drinker past year Ref Ref

Low (AUDIT\<8) 1.21 .108 0.96-1.54 0.93 .619 0.68-1.26

High (AUDIT 8+) 1.49 .006 1.12-1.98 1.00 .996 0.68-1.47

Physical activity Inactive Ref Ref

Moderately inactive 0.87 .569 0.53-1.42 1.13 .668 0.64-1.99

Moderately active 0.91 .655 0.59-1.40 1.09 .734 0.66-1.79

Active 1.10 .672 0.70-1.73 1.08 .775 0.64-1.81

Self-rated general health Poor/fair/good Ref Ref

Very good/excellent 2.19 \<.001 1.81-2.65 1.48 .001 1.18-1.84

Body Mass Index Under/Normal (\<25) Ref Ref

Overweight (25-29) 0.73 .012 0.57-0.93 0.77 .054 0.59-1.00

Obese (30-34) 0.43 \<.001 0.33-0.56 0.48 \<.001 0.35-0.65

Very obese (35+) 0.26 \<.001 0.18-0.38 0.35 \<.001 0.23-0.52

Diabetic No Ref Ref

Yes 0.30 \<.001 0.22-0.42 0.47 \<.001 0.32-0.68

CKD No Ref Ref

Yes 0.50 .005 0.31-0.81 0.66 .131 0.39-1.13

Depression (PHQ-9) No Ref Ref

Yes 0.68 \<.001 0.56-0.83 0.88 .288 0.69-1.11

Seen primary care doctor past year No Ref Ref

Yes 0.32 \<.001 0.26-0.39 0.38 \<.001 0.31-0.48

Reviewers\' comments:

Reviewer \#1:

The aim of the study is not clearly stated. I just assume it was (1) to determine the prevalence of untreated hypertension in population samples of Arkhangelsk and Novosibirsk and (2) to identify factors to be associated with untreated hypertension in the two population samples.

Response:

The reviewer is correct and we have amended the Introduction accordingly.

Section Materials and methods should be clearly structured having the following subsections: Population (this should also include how the individuals were selected), Screening examination (should be briefly described, including blood pressure measurement), Definition of risk factors (incl. hypertension).

Response:

We agree that the suggested structure will make the Methods section much clearer. We have now restructured and expanded the section accordingly.

The definition of hypertension used on lines 117 and 118 does not seem to include values equal to 140/90 mmHg, which is not in agreement with the quoted European guidelines on hypertension.

Response:

We have now phrased this with words, i.e. 'at or above 140' instead of '140+'. In this way it should be clearer that the guideline definition was indeed adhered to.

Reviewer \#2:

The submitted manuscript assesses the rate of untreated hypertension based on the «Know Your Heart» study and is carried out in two Russian cities, namely Novosibirsk and Arkhangelsk. The aim was also to provide further insights into the country-specific factors contributing to the fact that far too many hypertensive men and women currently remain untreated. However, there are a number of points, which need clarifications and revision.

1\) The Materials and Methods section is not enough conclusive. It is difficult to understand the methodology of the study. Although authors provided a reference to their comprehensive paper on the «Know Your Heart» study design \[Cook S, Malyutina S, Kudryavtsev AV, et al. Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18. Wellcome Open Res. 2018;3:67.\], it is not enough. I recommend to give in the current paper at least basic explanations on how the study population was selected.

Response:

Following the restructuring of the Methods section as suggested by Reviewer 1, we now also include a brief overview of the sampling and study components under the heading of 'Population'.

2\) The description of statistical methods is very scarce; they are presented literally in a couple of sentences and are not allocated in a separate subsection.

Response:

In the new structure of the Methods section, we now bring together the descriptions of the statistical analysis in a new sub-section.

3\) The robustness of results seems doubtful due to a low response rate. Moreover, the response rate in Novosibirsk, which is a developed city with a population of more than 1.5 million people, was more than two times lower than in Arkhangelsk (22% vs 51%, respectively). This issue must be addressed in some way.

Response:

Please see response to Editor's comments above.

4\) Within the scope of the studied problems, the psychosocial CVD risk factors such as depression, anxiety and stress are shown to be of great importance for the Russian population. These factors serve as barriers for traditional risk factors modification and CVD treatment, including hypertension treatment, and they are also known to independently affect long-term health outcomes in CVD patients. According to the design paper, the "Know Your Heart" study encompassed assessment of anxiety and depression (using validated questionnaires), as well as assessment of self-reported social support. It is not clear, why these data were not used in the multivariate logistic regression models of untreated vs treated hypertension in this paper. The inclusion of these data into the models may provide more accurate and comprehensive information on factors, associated with lack of antihypertensive treatment, specifically relevant for the Russian population.

Response:

We have included depression status (PHQ-9 instrument) in the analyses. Given that the constructs for depression, anxiety, and stress are related, we suggest that only the most severe of the three, i.e. depression, to be included. The results show that depression is borderline protective for untreated hypertension. This is consistent with the observation that hypertension is asymptomatic and less likely to be detected in individuals who are not in contact with the health system. Having other conditions, in this case, depression, may increase the probability of health system contact and treatment. While depression has been shown to affect individuals functionally in many ways, it cannot be concluded that it is a driver of untreated hypertension in the population at large.

5\) I would recommend avoiding inappropriate slang expressions like antihypertensives instead of antihypertensive drugs or medicines or treatment.

Response:

We now use the term, 'antihypertensive medications', throughout for clarity.

###### 

Submitted filename: Response to reviewers.docx

###### 

Click here for additional data file.
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Dear Dr. PETERSEN,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Bart Ferket

Academic Editor

PLOS ONE
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Dear Dr. Petersen:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Bart Ferket

Academic Editor
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